Non-Executive Chairman

Hans Peter Hasler

Hans Peter joined the Board of Shield Therapeutics plc in July 2018. His prior experience includes roles as COO at Elan Corporation, and several senior positions at Biogen, Inc., including Chief Operations Officer. Previously, Hans Peter was at Wyeth Pharmaceuticals as Senior Vice President, Chief Marketing Officer and Managing Director of Wyeth Group Germany, Wyeth-Lederle Switzerland, Austria and CEE.

Member of the Audit Committee and Nomination Committee.